Results 11 to 20 of about 4,692,840 (382)

Individualization of antiretroviral therapy

Pharmacogenomics and Personalized Medicine, 2011
Rebecca Pavlos, Elizabeth J PhillipsInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, AustraliaAbstract: Antiretroviral therapy (ART) has evolved considerably over the last three decades.
Pavlos R, Phillips EJ
doaj   +5 more sources

Initiating antiretroviral therapy

Southern African Journal of HIV Medicine, 2005
No abstract available.
Gary Maartens
doaj   +5 more sources

Antiretroviral Therapy [PDF]

Infectious Disease Clinics of North America, 2014
In this article, the scientific evidence and professional guidelines regarding the timing of antiretroviral therapy initiation are reviewed, with discussion of the increasingly persuasive evidence in favor of starting treatment early in the course of human immunodeficiency virus disease.
David A. Wohl, Christopher J. Sellers
openaire   +6 more sources

Hypertriglyceridemia in Antiretroviral Therapy [PDF]

Journal of the International AIDS Society, 2005
Elevated serum triglycerides, total cholesterol, very low-density lipoprotein (VLDL) cholesterol, and low-density lipoprotein (LDL) cholesterol have been reported in the literature from areas where experience with antiretroviral drugs has amassed. Up until recently the use of antiretroviral drugs in Nigeria on a wide scale was a rarity owing largely to
Emmanuel Pandy Kubeyinje, Frank Aiwansoba Imarhiagbe   +1 more
openaire   +4 more sources

Antiretroviral Therapy in the Clinic [PDF]

Journal of Virology, 2010
ABSTRACT Antiretroviral therapy in the developed world has resulted in substantial reductions in HIV-associated morbidity and mortality, changing an HIV diagnosis from a likely death sentence into a manageable chronic infection (F. J. Palella, Jr., K. M. Delaney, A. C. Moorman, M. O. Loveless, J. Fuhrer, G. A. Satten, D.
Martin S. Hirsch, Athe M. N. Tsibris
openaire   +3 more sources

"Nothing new": responses to the introduction of antiretroviral drugs in South Africa. [PDF]

, 2006
Interviews conducted in South Africa found that awareness of antiretroviral therapy was generally poor. Antiretroviral drugs were not perceived as new, but one of many alternative therapies for HIV/AIDS.
Chopra, Mickey, Doherty, Tanya M, Hill, Zelee, Kendall, Carl, Nkonki, Lungiswa L, Schaay, Nikki   +5 more
core   +1 more source

Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières [PDF]

, 2008
OBJECTIVES: To describe the use of second-line protease-inhibitor regimens in Médecins Sans Frontières HIV programmes, and determine switch rates, clinical outcomes, and factors associated with survival.
Alexandra Calmy, Boyd, Braitstein, Calmy, Calmy, Chaiwarith, Colebunders, Daniel O'Brien, Ferradini, Gallant, Galárraga, Ivers, Laurent, Ledergerber, Mar Pujades-Rodríguez, Mocroft, Nicastri, Orrell, Pierre Humblet, Renaud-Théry, Srasuebkul, Sungkanuparph, Vasan, Vekemans, Walmsley   +24 more
core   +2 more sources

Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

New England Journal of Medicine, 2016
BACKGROUND An interim analysis of data from the HIV Prevention Trials Network (HPTN) 052 trial showed that antiretroviral therapy (ART) prevented more than 96% of genetically linked infections caused by human immunodeficiency virus type 1 (HIV-1) in ...
M. Cohen, Y. Chen, M. McCauley, T. Gamble, M. Hosseinipour, N. Kumarasamy, J. Hakim, J. Kumwenda, B. Grinsztejn, J. Pilotto, S. Godbole, S. Chariyalertsak, B. Santos, K. Mayer, I. Hoffman, S. Eshleman, E. Piwowar-Manning, L. Cottle, X. Zhang, J. Makhema, L. Mills, R. Panchia, Sharlaa Faesen, J. Eron, J. Gallant, D. Havlir, S. Swindells, V. Elharrar, David Burns, T. Taha, K. Nielsen‐Saines, D. Celentano, M. Essex, S. Hudelson, A. Redd, T. Fleming   +35 more
semanticscholar   +1 more source

Outcomes of a remote, decentralized health center-based HIV/AIDS antiretroviral program in Zambia, 2003 to 2007 [PDF]

, 2009
A cross-sectional study of patients living with HIV/ AIDS treated during 2003 to 2007 in decentralized, rural health centers in Zambia was performed to measure virological outcomes after 12 months of antiretroviral therapy and identify factors associated
Elema, R, Lokuge, K, Mills, C, Mtonga, V, Nyirongo, N, O'Brien, D P, Ssonko, C, Tu, D, Verputten, M, Yun, O, Zulu, H   +10 more
core   +2 more sources

Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials. [PDF]

, 2009
BACKGROUND: Directly observed therapy has been recommended to improve adherence for patients with HIV infection who are on highly active antiretroviral therapy, but the benefit and cost-effectiveness of this approach has not been established conclusively.
Altice, Bayer, Berlin, Bussmann, Detsky, Edward J Mills, Farmer, Fleiss, Gross, Gross, Harrigan, Hedges, Hogg, Hozo, Jean B Nachega, Liechty, Lucas, Macalino, Maher, Mark E Engel, Maru, Maru, Maskew, Meade, Mills, Nachega, Nathan Ford, Osterberg, Page-Shipp, Pearson, Pearson, Pogue, Rigsby, Robert, Sackett, Sarna, Sherer, Simoni, Tam, Verma, Volmink, Wohl   +41 more
core   +3 more sources